Company intelligence
Genezen
Bringing Therapies to Life
About Genezen
Founded in 2014 in Indianapolis, IN, Genezen is a best-in-class gene therapy CDMO with over a decade of experience supporting the cell and gene therapy manufacturing market worldwide. With capabilities across vector-modalities (AAV, lentiviral, retroviral, and others), Genezen partners with innovator organizations to deliver potentially life-saving gene and cell therapies – from concept to commercial. With flexible and customer-centric programs, Genezen tailors its partnership-model approach to all sizes and stages of organizations, to make viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. Genezen’s state-of-the art Lexington, MA site holds multiple global regulatory licenses, including with the FDA, EMA, Health Canada, and MFDS Korea, in support of the active manufacture of a commercial viral vector-based product. Our Indianapolis, IN site provides cGMP manufacturing for viral vectors and is currently supporting a program entering a pivotal clinical trial.
Verified activity
Signals from Genezen
10 published signals
Presence & Recognition
Genezen celebrated colleagues across the cell and gene therapy community during Labor Day.
Reported by Genezen
Presence & Recognition
Genezen reached a milestone for the Huntington's disease community and for all of us at uniQure.
Reported by Matthew Kapusta
Presence & Recognition
Genezen is attending the Next Generation Cell & Gene Therapeutics conference in Boston from November 16 to 18.
Reported by Genezen
Presence & Recognition
Genezen is attending the Meeting on the Mesa in Phoenix from October 5 to 7.
Reported by Genezen
Presence & Recognition
Genezen is attending the ESGCT conference in Hamburg from October 27 to 30.
Reported by Genezen
Presence & Recognition
Genezen is attending the CPHI conference in Milan from October 6 to 8.
Reported by Genezen
Presence & Recognition
Genezen is attending the CAR-TCR Summit in Boston from September 15 to 17.
Reported by Genezen
Presence & Recognition
Genezen is attending the BioProcess International conference in Boston from September 22 to 25.
Reported by Genezen
Presence & Recognition
Genezen is attending the ASGCT Breakthroughs in Cell & Gene Therapy conference in Nashville from November 12 to 13.
Reported by Genezen
People
Genezen is currently hiring across Manufacturing, Quality, Analytical Development, and Process Development at its Indianapolis site.
Reported by Natasha Rivas